South Wales, July 8 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "Thalidomide BMS" on June 24. The details about the trademark application no. UK00004224008 published in the journal no. 2025/027 (July 4).
With Sipara Limited as representative, Bristol-Myers Squibb Company filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceutical preparations that contain thalidomide used to treat cancers and immune related diseases.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004224008
Disclaimer: Curated by HT Syndication.
